LightNews LightNews
alexanderford25.bsky.social
@alexanderford25.bsky.social
30 followers 39 following 11 posts
Posts Replies Media Videos
alexanderford25.bsky.social
Our latest network meta-analysis looking at efficacy of behavioural therapies in #IBS is now published online in
@LancetGastroHep

sciencedirect.com/science/arti...
Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis
Irritable bowel syndrome (IBS) management guidelines recommend that behavioural therapies, particularly brain–gut behaviour therapies, should be consi…
sciencedirect.com
October 10, 2025 at 11:49 AM
Reposted
lancetgastrohep.bsky.social
New research - Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis

www.thelancet.com/journals/lan...

#GastroSky #MedSky @alexanderford25.bsky.social @romegastropsych.bsky.social
Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis
Several behavioural therapies are efficacious for global symptoms in IBS, although the most evidence exists for those classed as brain–gut behaviour therapies. However, certainty in the evidence for a...
www.thelancet.com
October 10, 2025 at 11:47 AM
Reposted
robbrierley.bsky.social
New @lancetgastrohep.bsky.social

Non-inferiority of lyophilised faecal filtrate vs lyophilised donor stool was not established for the prevention of C difficile recurrence over 8 weeks

👉 Live 🦠 crucial in mediating clinical efficacy

www.thelancet.com/journals/lan...

#GISky #IDSky #MicroSky #FMT
September 23, 2025 at 1:13 PM
Reposted
johannahruddy.bsky.social
Medical students often view IBS as “less real” and harder to treat than IBD, biases that deepen with training. Since physician perceptions shape care, we must intervene early with education that frames IBS as legitimate and models compassionate, evidence-based care.
Medical students' knowledge and perception of irritable bowel syndrome in comparison to inflammatory bowel disease - PubMed
Biases observed in gastroenterologists toward patients with IBS originate as early as the beginning of medical school, including seeing IBS as a "less real" disease and more difficult to treat. Earlier educational interventions may be helpful in identifying and addressing these biases.
pubmed.ncbi.nlm.nih.gov
September 23, 2025 at 3:12 PM
Reposted
lancetgastrohep.bsky.social
Our July 2025 issue is out now at www.thelancet.com/gastrohep!

The issue includes content on alcohol and health, eosinophilic oesophagitis, hepatocellular carcinoma, pancreatic cancer, viral hepatitis, and much more...

#gastrosky #oncsky #idsky #medsky
June 5, 2025 at 5:35 AM
Reposted
robbrierley.bsky.social
Our latest issue is out now!

👇👇👇

#gastrosky #medsky #oncsky #hepsky
lancetgastrohep.bsky.social The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · Jun 5
Our July 2025 issue is out now at www.thelancet.com/gastrohep!

The issue includes content on alcohol and health, eosinophilic oesophagitis, hepatocellular carcinoma, pancreatic cancer, viral hepatitis, and much more...

#gastrosky #oncsky #idsky #medsky
June 5, 2025 at 1:17 PM
Reposted
bmj.com
Obituary for Rob Sapsford (1964-2024): Leeds cardiologist whose breadth of knowledge and sense of humour have left a huge hole.

Sapsford's warmth meant his office became an unofficial break room as colleagues would often pop in for a chat
www.bmj.com/content/389/...
Rob Sapsford
May 21, 2025 at 8:53 AM
Reposted
robbrierley.bsky.social
For patients with eosinophilic oesophagitis, etrasimod 2 mg once-daily treatment resulted in a significantly greater percentage decrease from baseline in oesophageal PEC versus placebo

#gastrosky #medsky
May 15, 2025 at 4:14 PM
Reposted
lancetgastrohep.bsky.social
What is the best diet for IBS?

www.medscape.com/viewarticle/...

via @medscape.com

#gastrosky #medsky @alexanderford25.bsky.social
What is the Best Diet for IBS?
A network meta-analysis of 28 trials evaluating dietary interventions for IBS found that reducing starch and sucrose ranked first in improving global symptoms.
www.medscape.com
May 8, 2025 at 1:10 PM
Reposted
heykatray.bsky.social
#gastrosky
April 26, 2025 at 1:04 PM
Reposted
natrevgastrohep.nature.com
New online! Common misconceptions and controversies in the management of irritable bowel syndrome
Common misconceptions and controversies in the management of irritable bowel syndrome
Nature Reviews Gastroenterology & Hepatology, Published online: 25 April 2025; doi:10.1038/s41575-025-01065-9This Perspective discusses misconceptions and controversies in the clinical management of irritable bowel syndrome (IBS), including diagnosis, testing and treatment, among others. Areas in which issues have been resolved and those that require further research and clarification are highlighted.
www.nature.com
April 26, 2025 at 12:37 AM
Reposted
lancetgastrohep.bsky.social
New @lancetchildadol.bsky.social - Efficacy of interventions for the treatment of irritable bowel syndrome, functional abdominal pain—not otherwise specified, and abdominal migraine in children

www.thelancet.com/journals/lan...

#IBSAwarenessMonth #GastroSky #MedSky #IBS #WorldIBSDay
Efficacy of interventions for the treatment of irritable bowel syndrome, functional abdominal pain—not otherwise specified, and abdominal migraine in children: a systematic review and network meta-ana...
Hypnotherapy and CBT show moderate certainty for treatment efficacy with clinically relevant effect sizes. No conclusions can be made about the other therapies and treatment success due to very low ev...
www.thelancet.com
April 25, 2025 at 10:18 AM
Reposted
lancetgastrohep.bsky.social
New Editorial - Breaking the cycle: time to invest in IBS

www.thelancet.com/journals/lan...

#WorldIBSDay #IBSAwarenessMonth #IBS #IrritableBowelSyndrome #GastroSky #MedSky
April 19, 2025 at 6:41 AM
alexanderford25.bsky.social
Breaking the cycle: time to invest in IBS - The Lancet Gastroenterology & Hepatology www.thelancet.com/journals/lan...
Breaking the cycle: time to invest in IBS
April marks Irritable Bowel Syndrome (IBS) Awareness Month, and April 19 World IBS Day, together aiming to raise awareness of this debilitating condition. Characterised by abdominal pain and a change ...
www.thelancet.com
April 19, 2025 at 8:25 AM
Reposted
lancetgastrohep.bsky.social
New research - Cuffe et al - Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis

www.thelancet.com/journals/lan...

#WorldIBSDay #IBSAwarenessMonth #GastroSky #MedSky #IBS #IrritableBowelSyndrome
Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis
In terms of dietary interventions for IBS, the most evidence exists for a low FODMAP diet, but other promising therapies are emerging and should be the subject of further study.
www.thelancet.com
April 19, 2025 at 6:46 AM
Reposted
lancetgastrohep.bsky.social
New research - Khasanaweh et al - Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis

www.thelancet.com/journals/lan...

#WorldIBSDay #IBSAwarenessMonth #IrritableBowelSyndrome #IBS #GastroSky #MedSky
Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis
Some gut–brain neuromodulators are efficacious in reducing global symptoms and abdominal pain in IBS. The findings support guidelines that recommend use of tricyclic antidepressants for ongoing global...
www.thelancet.com
April 19, 2025 at 6:47 AM
alexanderford25.bsky.social
Back to back papers from our group in @lancetgastrohep.bsky.social on #WorldIBSday 2025

Read them here:

www.thelancet.com/journals/lan...

www.thelancet.com/journals/lan...
Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis
Some gut–brain neuromodulators are efficacious in reducing global symptoms and abdominal pain in IBS. The findings support guidelines that recommend use of tricyclic antidepressants for ongoing global...
www.thelancet.com
April 19, 2025 at 7:58 AM
alexanderford25.bsky.social
On #WorldIBSDay2025 our updated meta-analysis of gut brain neuromodulators in #IBS is published in
@lancetgastrohep.bsky.social

www.thelancet.com/journals/lan...
Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis
Some gut–brain neuromodulators are efficacious in reducing global symptoms and abdominal pain in IBS. The findings support guidelines that recommend use of tricyclic antidepressants for ongoing global...
www.thelancet.com
April 19, 2025 at 7:56 AM
alexanderford25.bsky.social
On #WorldIBSDay2025 our updated network meta-analysis of dietary interventions in #IBS is published in
@lancetgastrohep.bsky.social

www.thelancet.com/journals/lan...
Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis
In terms of dietary interventions for IBS, the most evidence exists for a low FODMAP diet, but other promising therapies are emerging and should be the subject of further study.
www.thelancet.com
April 19, 2025 at 7:55 AM
alexanderford25.bsky.social
Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial gut.bmj.com/content/74/5...

Latest paper from the
@AtlantisTrial
in this months edition of
@Gut_BMJ
Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial
Background Low-dose amitriptyline, a tricyclic antidepressant (TCA), was superior to placebo for irritable bowel syndrome (IBS) in the AmitripTyline at Low-dose ANd Titrated for Irritable bowel syndro...
gut.bmj.com
April 8, 2025 at 5:59 PM
Reposted
amergastroassn.bsky.social
#DYK April is #IBSAwareness Month?

We join the IBS community and caretakers to raise awareness about this GI condition. IBS affects all patients differently. Use our clinical guidance for recommendations to treat this common GI condition: gastro.org/news/ibs-cli....
April 1, 2025 at 2:30 PM
Reposted
hmstaudacher.bsky.social
A must-listen for anyone working with people with DGBI 👇🏼 Great summary and experience from Alex Ford podcasts.apple.com/au/podcast/t...
#04: Professor Alex Ford - Navigating disorders of gut-brain interaction and IBS
Podcast Episode · Two guys talking **it - A Gastroenterology and Hepatology podcast · 22/01/2025 · 1h 11m
podcasts.apple.com
March 24, 2025 at 6:17 PM
Reposted
hmstaudacher.bsky.social
@alexanderford25.bsky.social
March 24, 2025 at 6:18 PM
Reposted
heykatray.bsky.social
New collection on the clinical #microbiome from @naturemedicine.bsky.social @naturemicrobiol.bsky.social @naturecomms.bsky.social @commsmed.bsky.social open for submissions!

More info on how to submit here www.nature.com/collections/...

#Gastrosky #microsky 🧪
screenshot of the collection page on The Clinical Microbiome
March 11, 2025 at 9:04 AM
Reposted
robbrierley.bsky.social
A masterclass review of the structure & function of the intestinal barrier, recent insights into the role of barrier function in chronic inflammatory & neoplastic diseases, plus novel concepts for treatment 👇👇👇

#GastroSky #MedSky #OncSky
lancetgastrohep.bsky.social The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · Mar 12
New Review - Neurath, Artis, Becker - The intestinal barrier: a pivotal role in health, inflammation, and cancer

www.thelancet.com/journals/lan...

#GastroSky #MedSky
March 12, 2025 at 11:11 AM